| Pharmaceutical Information |
| Drug Name |
Fluphenazine |
| Drug ID |
BADD_D00935 |
| Description |
A phenothiazine used in the treatment of psychoses. Its properties and uses are generally similar to those of chlorpromazine. |
| Indications and Usage |
For management of manifestations of psychotic disorders. |
| Marketing Status |
approved |
| ATC Code |
N05AB02 |
| DrugBank ID |
DB00623
|
| KEGG ID |
D07977
|
| MeSH ID |
D005476
|
| PubChem ID |
3372
|
| TTD Drug ID |
D0P5SA
|
| NDC Product Code |
Not Available |
| UNII |
S79426A41Z
|
| Synonyms |
Fluphenazine | Flufenazin | Fluphenazine Hydrochloride | Hydrochloride, Fluphenazine | Lyogen | Prolixin |
|
| Chemical Information |
| Molecular Formula |
C22H26F3N3OS |
| CAS Registry Number |
69-23-8 |
| SMILES |
C1CN(CCN1CCCN2C3=CC=CC=C3SC4=C2C=C(C=C4)C(F)(F)F)CCO |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
